Rachel Careccia, MD
Dermatopathology · Tampa, FLNPI 1194735688
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $311 of the $411 with a category attached, or 75.7%. 8 manufacturers reported payments, led by Johnson & Johnson at 41.2% of the total. Reporting peaked in 2023 at $287 and has fallen 93.2% since, to $19 in 2025. That places this record below the midpoint for dermatopathology clinicians in FL, where the typical reported total is $397.
Across 12 payments — averaging $34.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$169
- AbbVie$133
- UCB, Inc.$25
- DUSA Pharmaceuticals, Inc.$24
- Galderma Laboratories, L.p.$19
- Sun Pharmaceutical Industries Inc.$15
- plus $26 from 2 others
What the payments were for
- Food & beverage$31176%
- Education$10024%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 4 | $169 |
| AbbVie | 2 | $133 |
| UCB, Inc. | 1 | $25 |
| DUSA Pharmaceuticals, Inc. | 1 | $24 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $15 |
| LEO Pharma Inc. | 1 | $14 |
| Novartis | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Skyrizi$125
How this compares
$411 in reported general payments places this provider in the 50th percentile of 62 dermatopathology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 75 | $986 |
| Fluocinonide | 33 | $942 |
| Triamcinolone Acetonide | 43 | $618 |
| Doxycycline Hyclate | 15 | $441 |
| Ammonium Lactate | 15 | $361 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Tampa
- John MillnsTampa$8K
- Mustafa MohammadTampa$3K
- Sairekha RavichandranTampa$1K
- Lewis GlassTampa$803
- William EngTampa$767
- Hugh StoddardTampa$525
- Wei-Shen ChenTampa$397
- Mary ParisiTampa$218
- Paul Rodriguez-WaitkusTampa$192
- Manojkumar PatelTampa$122
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.